Everything You Need to Know About Vaping-Related Lung Illnesses and the Cannabis Industry
capjah/Adobe Stock

Everything You Need to Know About Vaping-Related Lung Illnesses and the Cannabis Industry

Licensed operators are in a unique position to educate the public and advance the research on this rash of illness and death in the U.S.

Subscribe
October 8, 2019

As the summer of 2019 drew to a close, the cannabis industry fixated on a rash of illnesses linked to vaping products. The focus has only grown more pronounced. As of Oct. 7, the Centers for Disease Control and Prevention had reported more than 1,000 cases of vaping-related pulmonary disease and at least 16 deaths. 

While the illnesses are linked to vaping products (and increasing in number every day), the science is still a murkier subject. State health officials and independent researchers are grappling with a fundamental problem: If the source of these illnesses is found in the illicit vape market, as investigations indicate, then how can the scientific community and law enforcement effectively prevent the spread of this disease?

What sort of public education responsibility falls to licensed cannabis businesses?

Here, we’re reserving a page on Cannabis Business Times and Cannabis Dispensary’s websites to maintain our record of how this story is unfolding. You’ll find our growing archive of news stories below, and we’ll continually update this page with the latest information and perspectives on this industry problem.

From the CDC:

What is causing this outbreak of lung injury?

  • The specific chemical exposure(s) causing lung injuries associated with e-cigarette use, or vaping, remains unknown at this time.
  • No single product or substance has been linked to all lung injury cases. The outbreak is occurring in the context of a dynamic marketplace for e-cigarette or vaping products, which may have a mix of ingredients, complex packaging and supply chains, and include potentially illicit substances. Users may not know what is in their e-cigarette or e-liquid solutions. Many of the products and substances can be modified by suppliers or users. They can be obtained from stores, online retailers, from informal sources (e.g. friends, family members), or “off the street.”
  • More information is needed to know whether one or more e-cigarette or vaping products, substances, or brand is responsible for the outbreak.

If there are questions you’d like to see answered or angles you’d like to share, please email Digital Editor Eric Sandy at esandy@gie.net.

Here are the stories we’ve published on Cannabis Business Times and Cannabis Dispensary to date:

Oct. 17: Washington Adopts Emergency Rules Regarding Flavored Vapor Products

Oct. 15: Colorado Regulators Prepare to Ban Certain Additives in Cannabis Vape Products

Oct. 7: Mayo Clinic: Vaping Illnesses Resemble Chemical Burns

Oct. 4: Oregon Governor Issues Temporary Ban on Flavored Vaping Products

Sept. 26: Medicine Man Pulls Vape Cartridges Containing Propylene Glycol or Vitamin E Acetate

Sept. 26: How Vaping Backlash Affects Major Tobacco-Backed Investments in Cannabis

Sept. 24: Massachusetts Will Ban All Vape Sales for Four Months

Sept. 19: Vape Sales Hold Steady for Many Retailers Following Weeks of Lung Disease Headlines, Chemical Uncertainty on the Illicit Market

Sept. 18: 3 Tips for Supply Chain Risk Management Amid Vaping-Related Lung Illnesses in the U.S.

Sept. 17: Hawaii Health Officials Pull CBD Products Following First Vaping-Related Lung Illness

Sept. 13: OLCC Provides Guidance to Recreational Marijuana Licensees on Vaping Illness Outbreak

Sept. 10: Special Report: Cannabis Researchers, Scientists Confront Vaping-Related Lung Disease Debate

Sept. 9: Vaping-Related Lung Disease Prompts Public Health Questions Across Cannabis Industry